---
schema_version: "secwatch.filing_event.v1"
accession: "0001822479-24-000015"
form_type: "8-K"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2024-05-02T23:59:59+00:00"
generated_at: "2026-06-03T00:49:38.109828+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sotera Health Q1 net rev up 12.5% to $248M; Adj EBITDA up 13.7%; reaffirms 2024 outlook

## Summary
- Q1 net rev $248M (+12.5% YoY); net income $6M ($0.02 EPS) vs $3M ($0.01) YoY.
- Adj EBITDA $112M (+13.7% YoY); Adj EPS $0.13 flat YoY.
- Sterigenics segment net rev $166M (+4.1% YoY); segment income $86M (+3.6%).
- Company reaffirms 2024 outlook amid market headwinds.
- EPA finalized NESHAP update; Sterigenics expects to comply with emission control investments.

## SEC filing metadata
- accession: 0001822479-24-000015
- form_type: 8-K
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2024-05-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000182247924000015/0001822479-24-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000182247924000015/shc-20240502.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822479-24-000015
- JSON: https://secwatch.observer/filing/0001822479-24-000015.json
- Plain text: https://secwatch.observer/filing/0001822479-24-000015.txt

## Key facts
- Earnings Releases
  Sotera Health Co reported three months ended March 31, 2024 results: revenue $248 million, net income $6 million, or $0.02 per diluted share, EPS $0.02 per diluted share. Guidance reaffirmed.
  - Period: three months ended March 31, 2024
  - Revenue: $248 million
  - Net income: $6 million, or $0.02 per diluted share
  - EPS: $0.02 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: incorporated by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Sotera Health Reports First-Quarter 2024 Results • Q1 2024 net revenues increased 12.5% to $248 million, compared to Q1 2023 • Q1 2024 net income of $6 million or $0.02 per diluted share, comp ared to net income of $3 million or $0.01 per diluted share in Q1 2023 • Q1 2024 Adjusted
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822479/000182247924000015/0001822479-24-000015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.